Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas P. Kazantzis"'
Autor:
Nicholas P. Kazantzis, Patrick W. Seow, Christopher W. Vaughan, Vanessa A. Mitchell, Sherelle L. Casey
Publikováno v:
British Journal of Pharmacology. 173:2521-2531
Background and Purpose Clinical studies have reported that pan-cannabinoid receptor agonists may have efficacy in neuropathic pain states and that this might be enhanced by co-administration with opioids. While cannabinoid–opioid analgesic synergy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ae9770d5cea8a60fe3593bfe330363f
https://doi.org/10.1111/bph.13534
https://doi.org/10.1111/bph.13534
Autor:
Nicholas P. Kazantzis, Vanessa A. Mitchell, Nicholas S. Adamson Barnes, Christopher W. Vaughan
Publikováno v:
British Journal of Pharmacology. 173:77-87
Background and Purpose While cannabinoids have been proposed as a potential treatment for neuropathic pain, they have limitations. Cannabinoid receptor agonists have good efficacy in animal models of neuropathic pain; they have a poor therapeutic win
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d08ecee48d1173e5dda60aa5c656d564
https://doi.org/10.1111/bph.13337
https://doi.org/10.1111/bph.13337
Autor:
Nicholas P, Kazantzis, Sherelle L, Casey, Patrick W, Seow, Vanessa A, Mitchell, Christopher W, Vaughan
Publikováno v:
British journal of pharmacology. 173(16)
Clinical studies have reported that pan-cannabinoid receptor agonists may have efficacy in neuropathic pain states and that this might be enhanced by co-administration with opioids. While cannabinoid-opioid analgesic synergy has been demonstrated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f44e6d4088937877ae2525cbd76d44a4
https://pubmed.ncbi.nlm.nih.gov/27278681
https://pubmed.ncbi.nlm.nih.gov/27278681
Autor:
Nicholas S, Adamson Barnes, Vanessa A, Mitchell, Nicholas P, Kazantzis, Christopher W, Vaughan
Publikováno v:
British journal of pharmacology. 173(1)
While cannabinoids have been proposed as a potential treatment for neuropathic pain, they have limitations. Cannabinoid receptor agonists have good efficacy in animal models of neuropathic pain; they have a poor therapeutic window. Conversely, select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e0f43f7384fb0b827e33e0a18beeb3c
https://pubmed.ncbi.nlm.nih.gov/26398331
https://pubmed.ncbi.nlm.nih.gov/26398331